February 07, 2026

The United States remains one of the world's largest and most strategically important chemical markets. However, introducing a new chemical substance into U.S. commerce requires compliance with the Toxic Substances Control Act (TSCA), a comprehensive regulatory framework administered by the U.S. Environmental Protection Agency (EPA).
Under TSCA, companies planning to manufacture, import, or process new chemical substances must undergo rigorous pre-market review processes designed to evaluate potential risks to human health and the environment. The cornerstone of this framework is the Premanufacture Notification (PMN) process, which requires EPA review before commercialization can begin.
In recent years, EPA has significantly increased scrutiny of chemical submissions, emphasizing risk-based assessments, environmental justice considerations, computational toxicology, and sustainable chemistry initiatives. As a result, organizations must adopt proactive compliance strategies to avoid delays, restrictions, or enforcement actions.
This comprehensive guide by Maven Regulatory Solutions explains TSCA requirements, PMN submissions, inventory determinations, exemptions, EPA review procedures, documentation requirements, fees, timelines, post-approval obligations, and emerging compliance trends shaping chemical regulation in 2026.
U.S. Chemical Regulatory Landscape
The Toxic Substances Control Act serves as the primary federal law governing industrial chemical substances in the United States.
TSCA authorizes EPA to evaluate chemicals before they enter commerce and to regulate substances that may present unreasonable risks.
EPA Regulatory Objectives
The agency evaluates:
•    Human health impacts
•    Environmental exposure risks
•    Worker safety considerations
•    Consumer exposure potential
•    Ecological effects
•    Environmental persistence
•    Bioaccumulation potential
•    Manufacturing and use conditions
EPA's objective is to ensure chemicals do not present unreasonable risk under their intended conditions of use.
Understanding TSCA Compliance
TSCA applies broadly to chemical substances manufactured, imported, processed, or distributed within the United States.
Activities Subject to TSCA Oversight
•    Chemical manufacturing
•    Chemical importation
•    Commercial processing
•    Distribution activities
•    Significant new uses of existing substances
•    Research and development activities (certain circumstances)
Compliance begins long before commercialization and should be integrated into product development planning.
What Is a Premanufacture Notification (PMN)?
A Premanufacture Notification (PMN) is the primary regulatory submission required before manufacturing or importing a new chemical substance.
The PMN provides EPA with information necessary to assess potential risks associated with the substance.
Purpose Of the PMN Process
EPA evaluates:
•    Chemical identity
•    Intended uses
•    Exposure potential
•    Hazard characteristics
•    Environmental fate
•    Worker protection measures
•    Risk management controls
Manufacture or import generally cannot begin until EPA review requirements are satisfied.
STEP 1: Determine TSCA Inventory Status
The first and most important compliance step is determining whether the substance already exists on the TSCA Inventory.
What Is the TSCA Inventory?
The TSCA Inventory is EPA’s official list of existing chemical substances currently recognized under TSCA.
A substance may appear as:
•    Public inventory listing
•    Confidential inventory listing
•    Existing chemical substances
•    New chemical substance requiring review
Inventory status directly determines whether PMN obligations apply.
When A PMN Is Required
A PMN is generally required when:
•    The substance is not listed on the TSCA Inventory
•    A Significant New Use Rule (SNUR) applies
•    Manufacturing conditions create new exposure scenarios
•    Existing use restrictions are exceeded
•    EPA determines additional review is necessary
Accurate inventory determinations are critical to regulatory planning.
Substances Excluded from TSCA Jurisdiction
Certain products are regulated under alternative federal authorities and therefore fall outside TSCA jurisdiction.
Common TSCA Exclusions
Product Category    Primary Regulatory Authority
Foods & Food Additives    FDA
Pharmaceuticals    FDA
Cosmetics    FDA
Medical Devices    FDA
Pesticides    EPA (FIFRA)
Tobacco Products    FDA
Nuclear Materials    NRC / DOE
Firearms Ammunition    ATF
Determining jurisdiction is often an important early regulatory assessment.
Materials Generally Exempt from PMN Requirements
Certain materials may not require PMN submissions.
Examples Include
•    Naturally occurring substances
•    Impurities
•    Certain by-products
•    Articles
•    Mixtures (though individual components may be regulated)
•    Materials manufactured solely for export under specific conditions
•    Regulatory interpretation should be carefully documented.
STEP 2: Evaluate Eligibility for TSCA Exemptions
EPA provides several exemptions designed to reduce regulatory burden for lower-risk activities.
Strategic use of exemptions can significantly accelerate commercialization timelines.
Common TSCA Exemptions
Exemption    Typical Applicability
Low Volume Exemption (LVE)    Limited annual production
Low Release & Low Exposure (LoREX)    Controlled exposure scenarios
Polymer Exemption    Eligible low-risk polymers
Research & Development Exemption    Scientific investigation
Test Marketing Exemption (TME)    Limited commercial evaluation
Eligibility depends on specific regulatory criteria.
Benefits Of Exemption Strategies
Appropriately utilized exemptions may offer:
•    Faster regulatory pathways
•    Reduced submission requirements
•    Lower compliance costs
•    Earlier market evaluation opportunities
•    Reduced Administrative Burden
However, exemption misuse may result in enforcement actions.
STEP 3: Pre-Submission Planning and Regulatory Strategy
Strong preparation significantly improves PMN outcomes.
EPA encourages early engagement and thorough regulatory planning.
Benefits Of Pre-Notice Consultations
Pre-submission interactions may help:
•    Clarify EPA expectations
•    Identify data gaps
•    Reduce review delays
•    Improve submission quality
•    Discuss hazard assessment approaches
•    Align risk evaluation strategies
Early engagement often improves predictability.
Core PMN Documentation Requirements
Comprehensive documentation supports efficient EPA review.
Key Submission Elements
Data Category    Information Required
Chemical Identity    Structure, composition, formula
Manufacturing Process    Process descriptions and flow diagrams
Production Volume    Estimated quantities
Use Information    Industrial, commercial, consumer uses
Exposure Assessment    Worker and environmental exposure
Environmental Fate    Persistence and degradation data
Hazard Information    Toxicology and ecotoxicology
By-products    Characterization and controls
Disposal Practices    Waste management information
Safety Data Sheets    Supporting safety information
Incomplete submissions remain a common cause of delays.
Hazard Assessment Expectations
EPA increasingly relies on a combination of traditional and alternative assessment approaches.
Hazard Information Sources
•    Experimental toxicology data
•    Read-across assessments
•    QSAR modeling
•    New Approach Methodologies (NAMs)
•    Published scientific literature
•    Analog substance evaluations
Scientific justification remains essential.
STEP 4: PMN Submission and EPA Review
All PMN submissions are filed electronically through EPA’s regulatory systems.
Submission Process Overview
Stage    Activity
Submission    PMN filing
Administrative Review    Completeness verification
Technical Assessment    Hazard and exposure evaluation
Risk Determination    Regulatory decision
Final Action    Approval, restriction, or additional requirements
EPA evaluates each submission using a risk-based framework.
TSCA PMN Fees (2026)
EPA periodically updates fee structures.
Typical PMN Fee Categories
Applicant Type    Approximate Fee
Standard Applicant    ~$37,000
Qualified Small Business    ~$6,480
Certain Exemptions    Reduced fees may apply
Applicants should verify current fee schedules before submission.
EPA Risk Evaluation Timeline
EPA generally conducts PMN reviews within statutory review periods.
Typical Review Process
Review Phase    Activities
Initial Screening    Administrative review
Exposure Assessment    Use and exposure evaluation
Hazard Analysis    Toxicological assessment
Risk Characterization    Integrated risk determination
Final Decision    Regulatory outcome
Although statutory review periods often begin at 90 days, extensions may occur.
Potential EPA Decisions
Following review, EPA may determine that a substance:
Possible Outcomes
•    Is not likely to present unreasonable risk
•    Requires risk management restrictions
•    Requires a Significant New Use Rule (SNUR)
•    Requires additional information
•    Cannot proceed without further evaluation
Each outcome carries distinct compliance obligations.
Understanding Significant New Use Rules (SNURs)
EPA may impose SNUR requirements when specific uses require additional review.
Common SNUR Triggers
•    New exposure scenarios
•    Increased production volumes
•    Consumer product applications
•    Occupational exposure concerns
•    Environmental release potential
Companies must monitor downstream compliance obligations carefully.
Post-Approval Obligations
Regulatory responsibilities continue after PMN review concludes.
Key Compliance Requirements
Manufacturers typically must:
•    Maintain required records
•    Follow EPA restrictions and consent orders
•    Submit a Notice of Commencement (NOC)
•    Monitor ongoing compliance obligations
•    Support downstream communication requirements
Post-market compliance remains an important regulatory priority.
Notice Of Commencement (NOC)
Once commercial manufacture begins, companies generally must submit a Notice of Commencement.
Purpose Of NOC Filing
NOC:
•    Confirms commercial manufacture has begun
•    Enables TSCA Inventory listing updates
•    Supports EPA recordkeeping requirements
Failure to submit required notices may result in compliance issues.
Common Reasons PMN Reviews Are Delayed
Many delays stem from avoidable deficiencies.
Frequent Challenges
•    Incomplete exposure information
•    Insufficient hazard data
•    Poorly defined use scenarios
•    Missing impurity characterizations
•    Inadequate worker protection descriptions
•    Limited environmental fate information
Strong submission quality can significantly reduce review complications.
Environmental Justice Considerations
EPA increasingly incorporates environmental justice assessments into chemical reviews.
Areas Of Regulatory Focus
•    Community exposure evaluations
•    Vulnerable population assessments
•    Cumulative risk considerations
•    Geographic exposure patterns
•    Worker protection measures
Environmental justice remains a growing component of EPA decision-making.
2026 Regulatory Trends in TSCA Compliance
Several emerging trends continue shaping chemical regulations.
Key Developments
•    Increased reliance on computational toxicology
•    Expansion of New Approach Methodologies (NAMs)
•    Greater scrutiny of PFAS substances
•    Enhanced environmental justice evaluations
•    Increased SNUR enforcement activity
•    Focus on sustainable chemistry initiatives
•    Greater transparency expectations
•    Stronger worker protection assessments
Companies should proactively monitor evolving EPA priorities.
Compliance Best Practices
Successful TSCA strategies often include:
•    Early inventory assessments
•    Regulatory pathway evaluations
•    Comprehensive hazard assessments
•    Pre-submission consultations
•    Strong documentation practices
•    Ongoing compliance monitoring
•    Proactive planning reduces regulatory uncertainty.
Quick Facts
•    TSCA regulates industrial chemical substances in the United States
•    EPA administers PMN reviews for new chemicals
•    PMNs are generally required before manufacturing or importing
•    Certain exemptions may reduce regulatory burden
•    EPA evaluates health and environmental risks
•    PMN reviews often require substantial technical documentation
•    Notice of Commencement filings are generally required after commercialization
•    Regulatory scrutiny continues increasing in 2026
Why TSCA Compliance Matters
Failure to comply with TSCA requirements may result in:
•    Market entry delays
•    Civil penalties
•    Import restrictions
•    Enforcement actions
•    Product commercialization barriers
•    Reputational risks
•    Operational disruptions
A robust compliance strategy supports successful market access.
How Maven Regulatory Solutions Supports TSCA Compliance
Our Services
•    TSCA Inventory assessments
•    PMN strategy development
•    Exemption evaluations
•    Regulatory pathway analysis
•    Hazard assessment support
•    Submission preparation and review
•    EPA interaction support
•    Post-approval compliance planning
Why Choose Maven
•    Deep chemical regulatory expertise
•    Practical compliance-focused strategies
•    Strong EPA regulatory knowledge
•    End-to-end submission support
•    Global chemical compliance capabilities
•    Up-to-date regulatory intelligence
Learn more at Maven Regulatory Solutions.
Planning To Introduce a New Chemical in the United States?
Whether developing specialty chemicals, industrial intermediates, polymers, advanced materials, or innovative chemical technologies, Maven Regulatory Solutions can help simplify TSCA compliance and support successful EPA submissions.
Contact Maven Regulatory Solutions For
•    TSCA Inventory reviews
•    PMN submission support
•    Exemption assessments
•    Hazard evaluation strategies
•    EPA regulatory consulting
•    SNUR compliance planning
•    Post-market compliance support
•    Chemical regulatory intelligence
Visit Maven Regulatory Solutions to connect with our chemical regulatory experts.
Conclusion
The U.S. TSCA framework remains one of the world's most influential chemical regulatory systems, requiring careful planning, scientific rigor, and proactive compliance management. Companies seeking to manufacture or import new chemical substances must navigate inventory assessments, exemption opportunities, PMN submissions, EPA risk evaluations, and ongoing post-market obligations.
Organizations that implement strong regulatory strategies, maintain high-quality documentation, and engage early with EPA expectations will be better positioned to achieve efficient market entry and long-term compliance success in the evolving chemical regulatory landscape.
Frequently Asked Questions
Q1. How can I determine whether a substance is listed on the TSCA Inventory?
Companies can conduct inventory searches through EPA resources or utilize confidential inventory inquiry procedures where appropriate.
Q2. Can a company manufacture a new chemical before PMN approval?
No. Manufacture or import generally cannot begin until applicable TSCA review requirements are satisfied.
Q3. Do all polymers require PMN submissions?
No. Certain qualifying polymers may be eligible for the Polymer Exemption.
Q4. What happens after EPA approves a PMN?
Manufacturers typically must comply with any conditions imposed by EPA and submit a Notice of Commencement once commercial manufacture begins.
Q5. Can PMN submission be withdrawn?
Yes. Applicants may voluntarily withdraw PMNs during the review process under certain circumstances.
Q6. What is SNUR?
A Significant New Use Rule requires additional EPA review before specific new uses of a chemical substance can occur.
Q7. Can Maven Regulatory Solutions support TSCA compliance?
Yes. Maven provides PMN strategy, TSCA inventory assessments, exemption evaluations, EPA submission support, and ongoing compliance consulting.